Page last updated: 2024-11-06

hexaconazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hexaconazole is a triazole fungicide that acts by inhibiting the biosynthesis of ergosterol, a vital component of fungal cell membranes. Its synthesis involves a multi-step process, starting with the reaction of 1,2,4-triazole with an appropriate alkyl halide followed by a series of reactions to introduce the desired substituents. Hexaconazole is highly effective against a broad spectrum of fungal diseases in a wide range of crops, including wheat, barley, rice, and fruit trees. Its importance lies in its ability to control fungal infections, protect crops from yield losses, and improve food security. Extensive research on hexaconazole focuses on its mode of action, efficacy against different fungal species, environmental fate, and potential risks to non-target organisms. Understanding these aspects is crucial for optimizing its application and minimizing its negative impacts.'

2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol : A member of the class of triazoles that is 1-hexyl-1H-1,2,4-triazole in which the hydrogens at position 2 of the hexyl chain are replaced by hydroxy and 2,4-dichlorophenyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

hexaconazole : A racemate comprising equimolar amounts of (R)- and (S)-hexaconazole. An agricultural fungicide introduced in the 1980s, it is not approved for use within the European Union. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID66461
CHEMBL ID1898860
CHEBI ID83711
SCHEMBL ID21992
MeSH IDM0364690

Synonyms (65)

Synonym
AC-16157
LS-14301
1h-1,2,4-triazole-1-ethanol, alpha-butyl-alpha-(2,4-dichlorophenyl)-
NCGC00164270-01
1h-1,2,4-triazole-1-ethanol, alpha-butyl-alpha-(2,4-dichlorophenyl)-, (+-)-
anvil l
anvil liquid
anvil
r 154523
pp 523
sitara
alpha-butyl-alpha-(2,4-dichlorophenyl)-1h-1,2,4-triazole-1-ethanol (+-)-
contaf 5ec
(rs)-2-(2,4-dichlorophenyl)-1-(1h-1,2,4-triazol-1-yl)hexan-2-ol
anvil (fungicide)
contaf
fd 4053
chlortriafol
hexaconazole [bsi:iso]
79983-71-4
2-(2,4-dichlorophenyl)-1-(1h-1,2,4-triazol-1-yl)hexan-2-ol
hexaconazole
NCGC00164270-02
2-(2,4-dichlorophenyl)-1-(1,2,4-triazol-1-yl)hexan-2-ol
FT-0655723
A839797
NCGC00164270-03
C18466
ec 413-050-7
unii-sx9r3x1fqv
sx9r3x1fqv ,
tox21_300684
cas-79983-71-4
NCGC00254592-01
dtxcid2014653
dtxsid4034653 ,
chebi:83711 ,
CHEMBL1898860
rs-2-(2,4-dichlorophenyl)-1-(1h-1,2,4-triazol-1-yl)hexan-2-ol
hexaconazol
AKOS015895354
SCHEMBL21992
(+/-)-hexaconazole
r-154523
pp-523
hexaconazole [iso]
hexaconazole, (+/-)-
pc-1002 ,
1h-1,2,4-triazole-1-ethanol, .alpha.-butyl-.alpha.-(2,4-dichlorophenyl)-
planete
hexaconazole [mi]
CS-5814
HY-A0278
.alpha.-butyl-.alpha.-(2,4-dichlorophenyl)-1h-1,2,4-triazole-1-ethanol (.+/-.)-
2-(2,4-dichlorophenyl)-1-(1h-1,2,4-triazol-1-yl)-2-hexanol #
1h-1,2,4-triazole-1-ethanol, .alpha.-butyl-.alpha.-(2,4-dichlorophenyl)-, (.+/-.)-
hexaconazol, pestanal(r), analytical standard
hexaconazole 100 microg/ml in acetonitrile
hexaconazole 10 microg/ml in cyclohexane
Q424794
hexaconzole
hexaconazole 1000 microg/ml in toluene
(-)-hexaconazol
F87564
(+/-)-2-(2,4-dichlorophenyl)-1-(1h-1,2,4-triazol-1-yl)-2-hexanol

Research Excerpts

Overview

Hexaconazole (HEZ) is a triazole fungicide registered to prevent and control grey mold disease on tomatoes. Nanohexaconazol is a highly efficient fungicide against Rhizoctonia solani.

ExcerptReferenceRelevance
"Hexaconazole (HEZ) is a triazole fungicide registered to prevent and control grey mold disease on tomatoes. "( Hexaconazole Application Saves the Loss of Grey Mold Disease but Hinders Tomato Fruit Ripening in Healthy Plants.
Cai, C; Deng, Y; Diao, J; Liu, R; Zheng, M; Zhou, Z, 2022
)
3.61
"Hexaconazole is a triazole fungicide, which is stable and difficult to degrade in the environment. "( Characterization of hexaconazole-degrading strain Sphingobacterium multivorum and analysis of transcriptome for biodegradation mechanism.
An, X; Dong, F; Liu, X; Tian, C; Wu, X; Xu, J; Zheng, Y, 2020
)
2.32
"Hexaconazole is a potential fungicide to be used in the oil palm plantation for controlling the basal stem root (BSR) disease caused by Ganoderma boninense. "( Dissipation of the fungicide hexaconazole in oil palm plantation.
Halimah, M; Idris, AS; Ismail, S; Maznah, Z, 2015
)
2.15
"Nanohexaconazole is a highly efficient fungicide against Rhizoctonia solani. "( Effect of Nanohexaconazole on Nitrogen Fixing Blue Green Algae and Bacteria.
Alam, MI; Chauhan, N; Gogoi, R; Gopal, M; Goswami, A; Kumar, R; Nair, KK; Pabbi, S; Paul, S; Singh, PK; Srivastava, C; Yadav, S, 2016
)
1.35
"Hexaconazole is a chiral fungicide used on a variety of crops for the control of many fungal diseases."( Studies of enantiomeric degradation of the triazole fungicide hexaconazole in tomato, cucumber, and field soil by chiral liquid chromatography-tandem mass spectrometry.
Chen, X; Dong, F; Han, Y; Li, Y; Liang, X; Liu, X; Xu, J; Zheng, Y, 2013
)
1.35

Toxicity

Nanohexaconazole was tested in vitro and there were no significant adverse effect in their numbers observed. This proved the safety of the nanofungicide.

ExcerptReferenceRelevance
"Little is known about the bioaccumulation and toxicity of hexaconazole (HEX) in spite of the fact that they are indispensable parts for a comprehensive assessment of its environmental behavior and toxic effects in organisms of freshwater ecosystems."( Enantioselective bioaccumulation of hexaconazole and its toxic effects in adult zebrafish (Danio rerio).
Li, D; Teng, M; Wang, Y; Xu, L; Zhang, R; Zhou, Z; Zhu, W, 2015
)
0.94
" Impact of nanohexaconazole on soil nitrifiers was tested in vitro and there were no significant adverse effect in their numbers observed as compared to conventional registered formulation, proving the safety of the nanofungicide."( Development and Quality Control of Nanohexaconazole as an Effective Fungicide and Its Biosafety Studies on Soil Nitifiers.
Alam, MI; Gogoi, R; Gopal, M; Goswami, A; Kumar, R; Nair, KK; Singh, PK; Srivastava, C, 2015
)
1.04
"The widespread application of triazole fungicides makes people attach great concern over its adverse effects in mammalian."( Comparative cytotoxic effects of five commonly used triazole alcohol fungicides on human cells of different tissue types.
Huang, Q; Liu, X; Muhayimana, S; Xiong, H; Xu, J; Xue, Y; Zhang, X, 2020
)
0.56
"Although fungicides could be the best solution in combating fungal infections in crops, however, the phytotoxic level of fungicides to the crops should be tested first to ensure that it is safe for the crops."( Phytotoxicity of chitosan-based agronanofungicides in the vegetative growth of oil palm seedling.
Daim, LDJ; Fakurazi, S; Hilmi, NHZ; Hussein, MZ; Idris, AS; Maluin, FN; Yusof, NA, 2020
)
0.56

Bioavailability

ExcerptReferenceRelevance
" However, it was observed that high accumulation of the fungicide in the stem tissue and leaf after the treatment using the chitosan-hexaconazole nanoparticles, which is good for better bioavailability for the treatment of the fungi, Ganoderma boninense."( Residual analysis of chitosan-based agronanofungicides as a sustainable alternative in oil palm disease management.
Daim, LDJ; Fakurazi, S; Hilmi, NHZ; Hussein, MZ; Idris, AS; Maluin, FN; Maznah, Z; Yusof, NA, 2020
)
0.76
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
chelatorA ligand with two or more separate binding sites that can bind to a single metallic central atom, forming a chelate.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
triazolesAn azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms.
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (32)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency79.64070.007215.758889.3584AID1224835
pregnane X receptorRattus norvegicus (Norway rat)Potency12.58930.025127.9203501.1870AID651751
RAR-related orphan receptor gammaMus musculus (house mouse)Potency52.90500.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency18.94800.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency47.01280.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743042; AID743054; AID743063
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency61.06840.013326.981070.7614AID1346978
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency48.50840.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency24.11480.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency39.13990.000417.946075.1148AID1346784; AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency35.36550.000214.376460.0339AID588532; AID720691; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency50.09490.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency30.11630.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency47.62400.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency54.91410.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency34.49010.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.49680.000229.305416,493.5996AID1259244; AID1259248; AID588513; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency49.79130.001024.504861.6448AID588534; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency44.37650.001019.414170.9645AID588536; AID743140
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency47.09960.023723.228263.5986AID743241
caspase-3Homo sapiens (human)Potency61.06840.013326.981070.7614AID1346978
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency48.50840.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency31.68250.001628.015177.1139AID1224843; AID1224895; AID1259385; AID1259395
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency41.24800.057821.109761.2679AID1159526; AID1159528
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency14.09540.010039.53711,122.0200AID588545; AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency59.91880.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency61.61460.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency40.52620.000627.21521,122.0200AID651741; AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency61.06840.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency76.88060.002319.595674.0614AID651631
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency61.06840.001551.739315,848.9004AID1259244
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency61.06840.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency61.06840.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (141)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (40)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (95)

Assay IDTitleYearJournalArticle
AID1419497Antifungal activity against ITC and FLC-susceptible Candida albicans ATCC MYA-2310 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419532Hemolytic activity in mouse erythrocytes assessed as hemolysis level at 1.95 ug/ml incubated for 1 hr at 37 degC2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081953Antifungal activity against Rhizoctonia solani assessed as growth inhibition at 7.25 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081952Antifungal activity against Rhizoctonia bataticola assessed as growth inhibition at 31 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081945Antifungal activity against Pythium aphanidermatum assessed as growth inhibition at 15.50 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1090398Antifungal activity against Athelia rolfsii assessed as inhibition of fungal growth2006Journal of agricultural and food chemistry, Mar-22, Volume: 54, Issue:6
Antifungal activity of 4-methyl-6-alkyl-2H-pyran-2-ones.
AID1419559Selectivity index, ratio of EC100 for toxicity in human A549 cells to MIC50 for antifungal activity against Aspergillus flavus ATCC MYA-36312017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419562Selectivity index, ratio of EC100 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against Aspergillus nidulans ATCC 381632017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419550Selectivity index, ratio of EC50 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against ITC and FLC-resistant Candida albicans ATCC 12372017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1092232Antifungal activity against Alternaria porri by food poison technique2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis of novel 12-aryl-8,9,10,12-tetrahydrobenzo[a]xanthene-11-thiones and evaluation of their biocidal effects.
AID1419561Selectivity index, ratio of EC100 for toxicity in human A549 cells to MIC50 for antifungal activity against Aspergillus nidulans ATCC 381632017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081385Fungicidal activity against Fusarium oxysporum by poisoned food technique2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis of nalidixic acid based hydrazones as novel pesticides.
AID1419547Selectivity index, ratio of EC50 for toxicity in human A549 cells to MIC50 for antifungal activity against ITC and FLC-susceptible Candida albicans ATCC MYA-23102017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419502Antifungal activity against Candida parapsilosis ATCC 22019 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1080819Fungicidal activity against Athelia rolfsii assessed as fungal growth inhibition at 28 degC by poisoned food technique2009Journal of agricultural and food chemistry, Sep-23, Volume: 57, Issue:18
Schiff bases as potential fungicides and nitrification inhibitors.
AID1419498Antifungal activity against ITC and FLC-resistant Candida albicans ATCC 1237 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419494Antifungal activity against Candida albicans ATCC 64124 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1110724Antifungal activity against Fusarium sp. assessed as fungal growth (Rvb = 77 mm)2000Farmaco (Societa chimica italiana : 1989), May, Volume: 55, Issue:5
Studies on arylfuran derivatives. Part XI. Synthesis, characterisation and biological studies on some Mannich bases carrying 2,4-dichlorophenylfurfural moiety.
AID1419552Selectivity index, ratio of EC50 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against ITC and FLC-resistant Candida albicans ATCC MYA-10032017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1090395Antifungal activity against Macrophomina phaseolina assessed as inhibition of fungal growth2006Journal of agricultural and food chemistry, Mar-22, Volume: 54, Issue:6
Antifungal activity of 4-methyl-6-alkyl-2H-pyran-2-ones.
AID1081388Fungicidal activity against Rhizoctonia bataticola by poisoned food technique2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis of nalidixic acid based hydrazones as novel pesticides.
AID1419533Hemolytic activity in mouse erythrocytes assessed as hemolysis level at 3.9 ug/ml incubated for 1 hr at 37 degC2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419499Antifungal activity against ITC and FLC-resistant Candida albicans ATCC MYA-1003 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419503Antifungal activity against Aspergillus flavus ATCC MYA-3631 incubated for 48 hrs by CLSI M38-A2 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419534Hemolytic activity in mouse erythrocytes assessed as hemolysis level at 7.8 ug/ml incubated for 1 hr at 37 degC2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419542Selectivity index, ratio of EC50 for toxicity in human A549 cells to MIC50 for antifungal activity against Candida albicans ATCC 641242017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419545Selectivity index, ratio of EC50 for toxicity in human A549 cells to MIC50 for antifungal activity against ITC and FLC-resistant Candida albicans ATCC MYA-908192017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419518Toxicity in human A549 cells assessed as reduction in cell viability at 15.6 ug/ml incubated for 24 hrs by resazurin dye based assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419496Antifungal activity against ITC and FLC-resistant Candida albicans ATCC MYA-90819 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419551Selectivity index, ratio of EC50 for toxicity in human A549 cells to MIC50 for antifungal activity against ITC and FLC-resistant Candida albicans ATCC MYA-10032017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1105386Antifungal activity against Athelia rolfsii ITCC 6181 by food poisoning method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1081386Fungicidal activity against Alternaria porri by poisoned food technique2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis of nalidixic acid based hydrazones as novel pesticides.
AID1419536Hemolytic activity in mouse erythrocytes assessed as hemolysis level at 31.3 ug/ml incubated for 1 hr at 37 degC2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419544Selectivity index, ratio of EC50 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against ITC and FLC-susceptible Candida albicans ATCC MYA-28762017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081941Antifungal activity against Pythium debaryanum assessed as growth inhibition at 7.25 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081387Fungicidal activity against Rhizoctonia solani by poisoned food technique2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis of nalidixic acid based hydrazones as novel pesticides.
AID1081949Antifungal activity against Fusarium udum assessed as growth inhibition at 31 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1419537Hemolytic activity in mouse erythrocytes assessed as hemolysis level at 62.5 ug/ml incubated for 1 hr at 37 degC2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419538Hemolytic activity in mouse erythrocytes assessed as hemolysis level at 125 ug/ml incubated for 1 hr at 37 degC2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1101069Fungicidal activity against Rhizoctonia solani infected Oryza sativa var. Nipponbare assessed per 10 acres applied by submerged-treatment 7 days prior to infection measured after 5 days2000Chemical & pharmaceutical bulletin, Aug, Volume: 48, Issue:8
Synthesis and systemic fungicidal activity of silicon-containing azole derivatives.
AID1419495Antifungal activity against ITC and FLC-susceptible Candida albicans ATCC MYA-2876 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419539Selectivity index, ratio of EC50 for toxicity in human A549 cells to MIC100 for antifungal activity against Candida albicans ATCC 102312017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419553Selectivity index, ratio of EC50 for toxicity in human A549 cells to MIC50 for antifungal activity against Candida glabrata ATCC 20012017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1092234Antifungal activity against Athelia rolfsii by food poison technique2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis of novel 12-aryl-8,9,10,12-tetrahydrobenzo[a]xanthene-11-thiones and evaluation of their biocidal effects.
AID1419501Antifungal activity against Candida krusei ATCC 6258 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081954Antifungal activity against Rhizoctonia solani assessed as growth inhibition at 15.50 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081958Antifungal activity against Athelia rolfsii assessed as growth inhibition at 31 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1419505Antifungal activity against Aspergillus terreus ATCC MYA-3633 incubated for 48 hrs by CLSI M38-A2 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081943Antifungal activity against Pythium debaryanum assessed as growth inhibition at 31 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081971Antifungal activity against Rhizoctonia bataticola assessed as growth inhibition by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081967Antifungal activity against Fusarium udum assessed as growth inhibition by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1419556Selectivity index, ratio of EC100 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against Candida krusei ATCC 62582017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081957Antifungal activity against Athelia rolfsii assessed as growth inhibition at 15.50 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081942Antifungal activity against Pythium debaryanum assessed as growth inhibition at 15.50 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081947Antifungal activity against Fusarium udum assessed as growth inhibition at 7.25 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1419543Selectivity index, ratio of EC50 for toxicity in human A549 cells to MIC50 for antifungal activity against ITC and FLC-susceptible Candida albicans ATCC MYA-28762017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419549Selectivity index, ratio of EC50 for toxicity in human A549 cells to MIC50 for antifungal activity against ITC and FLC-resistant Candida albicans ATCC 12372017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419541Selectivity index, ratio of EC50 for toxicity in human BEAS2B cells to MIC100 for antifungal activity against Candida albicans ATCC 102312017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081959Antifungal activity against Pythium debaryanum assessed as growth inhibition by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1419515Toxicity in human BEAS2B cells assessed as reduction in cell viability incubated for 24 hrs by resazurin dye based assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081956Antifungal activity against Athelia rolfsii assessed as growth inhibition at 7.25 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1419493Antifungal activity against Candida albicans ATCC 10231 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419557Selectivity index, ratio of EC100 for toxicity in human A549 cells to MIC50 for antifungal activity against Candida parapsilosis ATCC 220192017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419554Selectivity index, ratio of EC50 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against Candida glabrata ATCC 20012017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419535Hemolytic activity in mouse erythrocytes assessed as hemolysis level at 15.6 ug/ml incubated for 1 hr at 37 degC2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419558Selectivity index, ratio of EC100 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against Candida parapsilosis ATCC 220192017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419514Toxicity in human A549 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin dye based assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1080818Fungicidal activity against Rhizoctonia bataticola assessed as fungal growth inhibition at 28 degC by poisoned food technique2009Journal of agricultural and food chemistry, Sep-23, Volume: 57, Issue:18
Schiff bases as potential fungicides and nitrification inhibitors.
AID1081963Antifungal activity against Pythium aphanidermatum assessed as growth inhibition by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1090396Antifungal activity against Rhizoctonia bataticola assessed as inhibition of fungal growth2006Journal of agricultural and food chemistry, Mar-22, Volume: 54, Issue:6
Antifungal activity of 4-methyl-6-alkyl-2H-pyran-2-ones.
AID1419548Selectivity index, ratio of EC50 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against ITC and FLC-susceptible Candida albicans ATCC MYA-23102017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1090393Antifungal activity against Pythium debaryanum assessed as inhibition of fungal growth2006Journal of agricultural and food chemistry, Mar-22, Volume: 54, Issue:6
Antifungal activity of 4-methyl-6-alkyl-2H-pyran-2-ones.
AID1419540Selectivity index, ratio of EC50 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against Candida albicans ATCC 641242017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081955Antifungal activity against Rhizoctonia solani assessed as growth inhibition at 31 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1105385Antifungal activity against Rhizoctonia solani ITCC 5563 by food poisoning method2013European journal of medicinal chemistry, Jan, Volume: 59Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives.
AID1081951Antifungal activity against Rhizoctonia bataticola assessed as growth inhibition at 15.50 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081389Fungicidal activity against Athelia rolfsii by poisoned food technique2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis of nalidixic acid based hydrazones as novel pesticides.
AID1092233Antifungal activity against Fusarium oxysporum by food poison technique2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis of novel 12-aryl-8,9,10,12-tetrahydrobenzo[a]xanthene-11-thiones and evaluation of their biocidal effects.
AID1081979Antifungal activity against Athelia rolfsii assessed as growth inhibition by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1090397Antifungal activity against Rhizoctonia solani Nees assessed as inhibition of fungal growth2006Journal of agricultural and food chemistry, Mar-22, Volume: 54, Issue:6
Antifungal activity of 4-methyl-6-alkyl-2H-pyran-2-ones.
AID1081944Antifungal activity against Pythium aphanidermatum assessed as growth inhibition at 7.25 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081950Antifungal activity against Rhizoctonia bataticola assessed as growth inhibition at 7.25 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1081975Antifungal activity against Rhizoctonia solani assessed as growth inhibition by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1419519Toxicity in human BEAS2B cells assessed as reduction in cell viability at 15.6 ug/ml incubated for 24 hrs by resazurin dye based assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419504Antifungal activity against Aspergillus nidulans ATCC 38163 incubated for 48 hrs by CLSI M38-A2 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419500Antifungal activity against Candida glabrata ATCC 2001 incubated for 48 hrs by modified CLSI M27-A3 protocol based method2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1090394Antifungal activity against Pythium aphanidermatum assessed as inhibition of fungal growth2006Journal of agricultural and food chemistry, Mar-22, Volume: 54, Issue:6
Antifungal activity of 4-methyl-6-alkyl-2H-pyran-2-ones.
AID1081946Antifungal activity against Pythium aphanidermatum assessed as growth inhibition at 31 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
AID1419560Selectivity index, ratio of EC100 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against Aspergillus flavus ATCC MYA-36312017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419555Selectivity index, ratio of EC100 for toxicity in human A549 cells to MIC50 for antifungal activity against Candida krusei ATCC 62582017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419564Selectivity index, ratio of EC100 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against Aspergillus terreus ATCC MYA-36332017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1419546Selectivity index, ratio of EC50 for toxicity in human BEAS2B cells to MIC50 for antifungal activity against ITC and FLC-resistant Candida albicans ATCC MYA-908192017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1092235Antifungal activity against Rhizoctonia bataticola by food poison technique2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis of novel 12-aryl-8,9,10,12-tetrahydrobenzo[a]xanthene-11-thiones and evaluation of their biocidal effects.
AID1419563Selectivity index, ratio of EC100 for toxicity in human A549 cells to MIC50 for antifungal activity against Aspergillus terreus ATCC MYA-36332017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1081948Antifungal activity against Fusarium udum assessed as growth inhibition at 15.50 ug/ml by poisoned food technique2011Journal of agricultural and food chemistry, Mar-23, Volume: 59, Issue:6
Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (91)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's23 (25.27)29.6817
2010's51 (56.04)24.3611
2020's17 (18.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.03 (24.57)
Research Supply Index4.52 (2.92)
Research Growth Index5.30 (4.65)
Search Engine Demand Index108.95 (26.88)
Search Engine Supply Index3.85 (0.95)

This Compound (40.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (1.10%)4.05%
Observational0 (0.00%)0.25%
Other90 (98.90%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]